Neurokinin antagonist 1 

Neurokinin antagonist 1 is a Neurokinin antagonist extracted from patent WO1998045262A1.

Neurokinin^[1]

The invention in the patent WO1998045262A1 refers to antagonists of the interaction between the P substance and the NK-1 receptor, the process for their preparation, and their use in pharmaceutical compositions which may be used in the treatment of pathological forms in which the P substance receptor is involved, and in particular in the treatment of the inflammation of airways, such as asthma and rhinitis, and in the treatment of emesis^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

600.75

C₃₈H₄₀N₄O₃

214487-45-3

CC(C=C1)=CC=C1CC(N(C)[C@H](CC2=CC3=CC=CC=C3C=C2)C(N[C@@H](CCCC4)[C@@H]4NC(C5=CNC6=C5C=CC=C6)=O)=O)=O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Sisto Alessandro, et al. Pseudo-peptide compounds as antagonists of neurokinines. WO1998045262A1.